8-K: Jushi Holdings Reports Mixed Q4 and Full Year 2024 Results; Focus Shifts to Retail Expansion
Quarterly and Full Year Financial Results
Jushi Holdings Inc. announces its Q4 and full year 2024 financial results, highlighting a net loss reduction year-over-year but a revenue decrease, while outlining plans for retail expansion.
Summary
- Jushi Holdings Inc. reported its financial results for the fourth quarter and full year ended December 31, 2024.
- The company's full year 2024 net loss was $48.8 million, compared to a net loss of $65.1 million in 2023.
- Adjusted EBITDA for the full year 2024 was $46.2 million, compared to $40.8 million in 2023.
- The company experienced increased quarterly and annual operational cash flow, reaching $7.2 million and $21.6 million, respectively.
- Five new dispensaries have opened since the end of Q3 2024, with three more planned by Summer 2025.
- Q4 2024 total revenue was $65.9 million.
- Gross profit for Q4 2024 was $25.4 million, with a gross profit margin of 38.6%.
- Net loss for Q4 2024 was $12.5 million.
- Adjusted EBITDA for Q4 2024 was $8.0 million, with an Adjusted EBITDA margin of 12.2%.
- Cash, cash equivalents, and restricted cash were $21.3 million as of the end of Q4 2024.
- Net cash flows provided by operations for Q4 2024 were $7.2 million.
- Full year 2024 total revenue was $257.5 million.
- Gross profit for the full year was $118.3 million, with a gross profit margin of 45.9%.
- Net cash flows provided by operations for the full year were $21.6 million.
- The company is focusing on expanding its retail presence with the '7 and 7 initiative,' aiming to increase retail locations by 40% by mid-2026, starting with seven new dispensaries by mid-2025.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive due to improved profitability metrics (net loss reduction, EBITDA increase) and strategic retail expansion plans, but tempered by revenue declines and competitive pressures.
Positives
- The company reduced its net loss from $65.1 million in 2023 to $48.8 million in 2024.
- Adjusted EBITDA increased from $40.8 million in 2023 to $46.2 million in 2024.
- Operational cash flow improved significantly, reaching $21.6 million for the full year.
- Jushi is expanding its retail footprint with new dispensary openings and plans for further expansion.
- Jushi-branded product sales are increasing as a percentage of total retail revenue.
- The company strengthened its balance sheet through factoring employee retention credit claims.
- Gross profit margin increased to 45.9% for FY 2024 as compared to 43.1% for FY 2023, driven by operating efficiencies at cultivation and processing facilities.
Negatives
- Revenue decreased by $1.9 million in Q4 2024 compared to Q4 2023.
- Revenue decreased by $11.9 million for the full year 2024 compared to 2023.
- Retail revenue decreased in all states except Virginia and Ohio due to increased competition and market price compression.
- Wholesale revenue decreased due to competition and production challenges, leading to prioritization of retail stores.
- Gross profit margin decreased to 38.6% for Q4 2024 compared to 40.2% for Q4 2023, primarily due to production challenges in the wholesale channel.
Risks
- Increased competition and market price compression are negatively impacting retail revenue in several states.
- Production challenges in the wholesale channel are affecting gross profit margins.
- The company faces risks related to the U.S. regulatory landscape and enforcement related to cannabis.
- The company faces risks related to anti-money laundering laws and regulations.
- The company faces risks related to the economy generally, inflation, the rising cost of capital, and stock market instability.
Future Outlook
Jushi plans to expand its retail network across its core footprint with the '7 and 7 initiative,' aiming to increase retail presence by 40% by mid-2026, starting with the opening of seven new dispensaries by mid-2025. The company believes this expansion will drive revenue and profitability while enhancing operational efficiency and margin expansion.
Management Comments
- Jim Cacioppo, CEO, stated that the company strengthened its platform in 2024 by reducing debt, enhancing the balance sheet, and improving cash flows from operations.
- Mr. Cacioppo mentioned the focus has transitioned to driving growth and advancing the retail-first growth strategy through the expansion of the Beyond Hello retail banner.
- Mr. Cacioppo noted the company remains committed to building upon this momentum by expanding its retail network across its core footprint with the '7 and 7 initiative'.
Industry Context
Jushi's focus on retail expansion aligns with the broader trend of multi-state operators (MSOs) seeking to establish a strong presence in key cannabis markets. The company's emphasis on branded products and operational efficiency reflects the increasing competition and margin pressures in the industry.
Comparison to Industry Standards
- Compared to other MSOs like Curaleaf, Trulieve, and Green Thumb Industries, Jushi's revenue is smaller, reflecting its more focused market presence.
- Jushi's Adjusted EBITDA margin of 17.9% for FY 2024 is within the range of other MSOs, indicating reasonable operational efficiency.
- The company's strategy of focusing on retail expansion and branded products is similar to that of other successful MSOs.
- Jushi's debt levels are relatively high compared to some of its peers, which could pose a risk in a challenging economic environment.
Stakeholder Impact
- Shareholders may be concerned about the revenue decline but encouraged by the improved profitability and expansion plans.
- Employees may benefit from the company's growth and expansion.
- Customers will have access to more dispensaries and product offerings.
- Suppliers may see increased demand as the company expands its retail footprint.
- Creditors will be monitoring the company's debt levels and ability to generate cash flow.
Next Steps
- Continue expanding retail network with the '7 and 7 initiative'.
- Focus on opportunities in Illinois, Pennsylvania, New Jersey, and Ohio.
- Continue product innovation, highlighted by the Flower Foundry brand.
- Monitor and manage debt levels.
Key Dates
| Date | Description |
|---|---|
| March 6, 2025 | Date of report and press release announcing Q4 and full year 2024 financial results. |
| February 21, 2025 | Closed on the acquisition of two operating dispensaries in Oxford and Toledo, Ohio. |
| February 22, 2025 | Opened a new Beyond Hello location in Warren, Ohio. |
| February 25, 2025 | Issued 12% second lien notes due in 2026 and opened a relocated dispensary in Linwood, Pennsylvania. |
| March 6, 2025 | Conference call to discuss Q4 and full year 2024 financial results. |
| Summer 2025 | Planned opening of three more dispensaries. |
| Mid-2025 | Plan to expand retail presence by opening seven new dispensaries. |
| Mid-2026 | Target date to expand retail presence by 40%. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.